EMAS position statement: Testosterone replacement therapy in the aging male

Dimopoulou Christina; Ceausu Iuliana; Depypere Herman; Lambrinoudaki Irene; Mueck Alfred; Perez-Lopez Faustino R.; Rees Margaret; van der Schouw Yvonne T.; Senturk Levent M.; Simonsini Tommaso; Stevenson John C.; Stute Petra; Goulis Dimitrios G.

首页> 外文期刊>Maturitas: International Journal for the Study of the Climacteric >EMAS position statement: Testosterone replacement therapy in the aging male

【24h】

EMAS position statement: Testosterone replacement therapy in the aging male

机译：EMAS立场声明：老年男性中的睾丸激素替代疗法

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction: Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, characterized by the presence of symptoms (most usually of a sexual nature, such as decreased libido, decreased spontaneous erections and erectile dysfunction) and signs, in combination with low serum testosterone concentrations. Whether testosterone replacement therapy (TRT) should be offered to those individuals is still under extensive debate.

机译：简介：迟发性性腺功能低下（LOH）代表衰老男性的常见临床病征，其特征为与以下症状并存：症状（最常见的是性行为，例如性欲减退，自发性勃起和勃起功能障碍减少）和体征。血清睾丸激素浓度低。是否应向这些人提供睾丸激素替代疗法（TRT）仍在广泛争论中。

著录项

来源
《Maturitas: International Journal for the Study of the Climacteric》 |2016年第2期|共6页
作者
Dimopoulou Christina; Ceausu Iuliana; Depypere Herman; Lambrinoudaki Irene; Mueck Alfred; Perez-Lopez Faustino R.; Rees Margaret; van der Schouw Yvonne T.; Senturk Levent M.; Simonsini Tommaso; Stevenson John C.; Stute Petra; Goulis Dimitrios G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类人体生理学;
关键词
Late-onset hypogonadism; Testosterone replacement; Aging male;

机译：迟发性腺功能减退;睾丸激素替代;男性衰老;

相似文献

外文文献
中文文献
专利

1. EMAS position statement: Testosterone replacement therapy in the aging male [J] . Dimopoulou Christina, Ceausu Iuliana, Depypere Herman, Maturitas: International Journal for the Study of the Climacteric . 2016,第2期

机译：EMAS立场声明：老年男性中的睾丸激素替代疗法
2. Testosterone replacement therapy for male aging: ASA position statement. [J] . Journal of Andrology . 2006,第2期

机译：男性衰老的睾丸激素替代疗法：ASA立场声明。
3. Testosterone replacement therapy for male aging: ASA position statement. [J] . Journal of Andrology . 2006,第2期

机译：男性衰老的睾丸激素替代疗法：ASA立场声明。
4. Topical Testosterone Replacement Therapy Based on the Skin Penetration EnhancerSEPA~R [C] . T. Chan, A. Dobs, J. McMurray, International Congress of Andrology . 2005

机译：基于皮肤渗透的局部睾酮替代疗法〜r
5. The Long-Term Effects of Testosterone Replacement Therapy in Aging Males with Late-Onset Hypogonadism [D] . ?Clausen, Jonathan 2020

机译：睾酮替代疗法在衰老男性中的长期效应患有晚期失败的性腺
6. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy [O] . Georgios K. Dimitriadis, Harpal S. Randeva, Saboor Aftab, -1

机译：男性肥胖相关的继发性性腺功能减退症的肌肉代谢表型肌内睾丸酮十一酸酯治疗之前和之后的治疗
7. PIH24 Intra Muscular Testosterone Undecanoate (TU) (NEBIDO®) as Testosterone Replacement Therapy (TRT) for Androgen Deficiency in the Aging Male (ADAM) and Diabetes Mellitus Type 2 (DM2) Patients: Brazilian Economic Modeling [O] . Silva A.P., Santoni N.B., Pepe C., 2011

机译：PIH24十一酸肌内睾酮（TU）（NEBIDO®）作为老年男性（ADAM）和2型糖尿病（DM2）男性雄激素缺乏症的睾丸激素替代疗法（TRT）：巴西经济模型

EMAS position statement: Testosterone replacement therapy in the aging male

摘要

著录项

相似文献

相关主题

期刊订阅